Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 143 of 143 entries
View as:

Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc)

Phase: N/A Priority: Normal
NCT ID: NCT00706082 Org: User:
Start: 10/31/08 End: 03/31/12 Due: 03/31/13

OPsumit USers Registry

Phase: N/A Priority: Normal
NCT ID: NCT02126943 Org: User:
Start: 04/30/14 End: 04/24/20 Due: 04/24/21

A Study for the Identification of Biomarker Signatures for Diagnosis of Pulmonary Hypertension (PH) in Participants at Low or Intermediate Probability of PH Undergoing Cardiac Magnetic Resonance Imaging

Phase: N/A Priority: Normal
NCT ID: NCT04480723 Org: User:
Start: 12/11/20 End: 05/18/22 Due: 05/18/23

A Study of Macitentan in Children Below 2 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT05731492 Org: User:
Start: 03/14/24 End: 04/01/24 Due: 04/01/25

Safety and Efficacy of Miglustat in Chinese NPC Patients

Phase: N/A Priority: Normal
NCT ID: NCT03910621 Org: User:
Start: 04/02/20 End: 03/25/22 Due: 03/25/23

Combination Therapy in Pulmonary Arterial Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00433329 Org: User:
Start: 03/31/07 End: 08/31/10 Due: 08/31/11

Efficacy and Safety of Bosentan in Sickle Cell Disease (SCD) Patients With Pulmonary Arterial Hypertension (PAH)

Phase: N/A Priority: Normal
NCT ID: NCT00310830 Org: User:
Start: 03/31/06 End: 08/31/07 Due: 08/31/08

Study to Assess the Effect of Macitentan on the Electrocardiogram (ECG) in Healthy Male and Female Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02050802 Org: User:
Start: 08/31/11 End: 11/30/11 Due: 11/30/12

Extension of the Psychometric Validation Study ORCHESTRA in Patients With PAH

Phase: N/A Priority: Normal
NCT ID: NCT02112487 Org: User:
Start: 06/23/14 End: 09/19/18 Due: 09/19/19

A Study of Selexipag in Healthy Male Participant

Phase: N/A Priority: Normal
NCT ID: NCT04266756 Org: User:
Start: 01/23/20 End: 08/14/20 Due: 08/14/21

Study to Investigate the Absolute Bioavailability of a Single Oral Dose of Ponesimod in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02068235 Org: User:
Start: 08/31/14 End: 11/30/14 Due: 11/30/15

Clinical Study to Investigate Effect of Macitentan on Riociguat Pharmacokinetics

Phase: N/A Priority: Normal
NCT ID: NCT03389321 Org: User:
Start: 01/09/18 End: 02/06/18 Due: 02/06/19

Bosentan in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

Phase: N/A Priority: Normal
NCT ID: NCT00319111 Org: User:
Start: 01/31/06 End: 04/30/09 Due: 04/30/10

The "VISION" Trial: Ventavis Inhalation With Sildenafil to Improve and Optimize Pulmonary Arterial Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00302211 Org: User:
Start: 02/01/06 End: 07/01/08 Due: 07/01/09

Clinical Study to Evaluate the Effects of Macitentan on Exercise Capacity in Subjects With Eisenmenger Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT01743001 Org: User:
Start: 05/21/13 End: 12/01/16 Due: 12/01/17

Persistent Pulmonary Hypertension of the Newborn

Phase: N/A Priority: Normal
NCT ID: NCT01389856 Org: User:
Start: 12/31/11 End: 01/31/14 Due: 01/31/15

Absolute Bioavailability of a Single Oral Dose of Selexipag in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02882425 Org: User:
Start: 01/31/15 End: 04/30/15 Due: 04/30/16

Epoprostenol for Injection (EFI/ACT-385781A) - Pulmonary Arterial Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01431716 Org: User:
Start: 03/31/11 End: 07/31/12 Due: 07/31/13